Drug recall D-0428-2024

Class II Terminated reported Apr 3, 2024

Product

Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62

Reason for recall

Failed Dissolution Specifications

Lots and codes

Lot # 100039678, Exp 04/31/2024; 100038111, 100042277, Exp 07/31/2024

Recall details

Recalling firm
Teva Pharmaceuticals USA, Inc, Parsippany, NJ
Quantity
92,676 cartons
Distribution
USA nationwide.
Type
Voluntary: Firm initiated
Recall initiated
March 7, 2024
Terminated
March 6, 2025

Related products